GlassScriptPhysician profile
Rebecca Gray
NPI 1952501777
$459.59
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.97 · 2020: $53.69 · 2021: $19.42 · 2022: $253 · 2023: $94.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $175.89 | 2021-2022 | |
| Astellas Pharma US INC | $117.72 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.25 | 2022 | |
| Avion Pharmaceuticals | $28.05 | 2019-2020 | |
| Myovant Sciences INC. | $22.35 | 2022 | |
| Hologic Sales and Service, LLC | $18.15 | 2020 | |
| Exeltis, USA INC. | $16.44 | 2022 | |
| Merck Sharp & Dohme LLC | $12.94 | 2019 | |
| Coopersurgical, INC. | $10.80 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.